Single-dose KSI-101 demonstrates rapid, meaningful responses in MESI, independent of inflammation location or macular edema etiology Location of Inflammation Specific Macular Edema Etiology Idiopathic Juvenile Idiopathic Arthritis Focal Chorioretinal inflammation Punctate Inner Choroidopathy Post-Operative Macular Edema Day 1 Anterior Intermediate Posterior Panuveitis Day 1 Week 4 Effect of a single dose of KSI-101 Week 4 11
APEX Study Phase 1b Results on KSI-101 for Macular Edema Page 10 Page 12